DMF increased the expression of the downstream Nrf2 genes NQO1 and HO-1, which is consistent with its known effects on the Nrf2 pathway and provides a potential mechanism by which it could exert its therapeutic effects in preclinical models of epilepsy. The gene discussed is NQO1; the disease is epilepsy.